Simplex Trading
VIR icon

Simplex Trading’s Vir Biotechnology VIR Stock Holding History

Simplex Trading’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$794K Buy
88,600
+22,700
+34% +$181K ﹤0.01% 2732
2025
Q4 		$397K Buy
65,900
+51,700
+364% +$308K ﹤0.01% 3527
2025
Q3 		$81K Sell
14,200
-6,700
-32% -$34.3K ﹤0.01% 5990
2025
Q2 		$105K Buy
20,900
+7,100
+51% +$38.1K ﹤0.01% 5193
2025
Q1 		$89K Buy
13,800
+4,900
+55% +$43.6K ﹤0.01% 5178
2024
Q4 		$65K Sell
8,900
-17,600
-66% -$139K ﹤0.01% 5601
2024
Q3 		$198K Buy
26,500
+2,700
+11% +$23.5K ﹤0.01% 4525
2024
Q2 		$211K Sell
23,800
-27,400
-54% -$263K ﹤0.01% 4597
2024
Q1 		$518K Buy
51,200
+23,200
+83% +$236K ﹤0.01% 3833
2023
Q4 		$281K Buy
28,000
+14,600
+109% +$133K ﹤0.01% 4296
2023
Q3 		$125K Buy
13,400
+3,900
+41% +$55.6K ﹤0.01% 4869
2023
Q2 		$233K Sell
9,500
-39,500
-81% -$992K ﹤0.01% 4127
2023
Q1 		$1.14M Buy
49,000
+40,900
+505% +$1.05M ﹤0.01% 2475
2022
Q4 		$205K Sell
8,100
-3,900
-33% -$95.6K ﹤0.01% 4200
2022
Q3 		$231K Sell
12,000
-17,800
-60% -$453K ﹤0.01% 4422
2022
Q2 		$759K Buy
29,800
+19,000
+176% +$444K ﹤0.01% 2943
2022
Q1 		$277K Sell
10,800
-30,900
-74% -$916K ﹤0.01% 4663
2021
Q4 		$1.75M Buy
41,700
+37,976
+1,020% +$1.49M ﹤0.01% 2180
2021
Q3 		$162K Buy
3,724
+28
+0.8% +$1.21K ﹤0.01% 5937
2021
Q2 		$174K Buy
3,696
+3,362
+1,007% +$153K ﹤0.01% 5912
2021
Q1 		$501K Buy
+334
New +$18K ﹤0.01% 3378
2020
Q4 		– Sell
-114
Closed -$391K – 9146
2020
Q3 		$391K Sell
114
-20
-15% -$861 ﹤0.01% 3289
2020
Q2 		$548K Buy
134
+102
+319% +$3.42K ﹤0.01% 2788
2020
Q1 		$109K Buy
+32
New +$860 ﹤0.01% 4281

Other funds holding VIR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
GP
GSK plc London $599M AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Simplex Trading's VIR Position: Q4 2025 in Review

Simplex Trading sold out of Vir Biotechnology (VIR) in Q4 2025, closing a stake of 10,010 shares — an estimated $59.6K sold.

Simplex Trading first reported a position in VIR in Q1 2020 and held it in 16 quarters. The position peaked at $908K in Q4 2021. 218 funds tracked by Wall St. Rank hold VIR as of Q4 2025.

  • Simplex Trading reported no remaining Vir Biotechnology position as of Q4 2025 after selling out during the quarter.
  • Simplex Trading sold 10,010 Vir Biotechnology shares in Q4 2025, an estimated $59.6K.
  • Simplex Trading first reported a position in Vir Biotechnology in Q1 2020 and held it in 16 quarters.
  • Simplex Trading's Vir Biotechnology position peaked at $908K in Q4 2021.
  • 218 funds tracked by Wall St. Rank held Vir Biotechnology as of Q4 2025.

Based on Simplex Trading's 13F filing for Q4 2025, filed 11 Feb 2026.